SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-005419
Filing Date
2015-01-29
Accepted
2015-01-29 16:55:37
Documents
8
Period of Report
2015-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-3109_48k.htm 8-K 42106
2 EX-1.1 a15-3109_4ex1d1.htm EX-1.1 324995
3 EX-5.1 a15-3109_4ex5d1.htm EX-5.1 12169
4 EX-99.1 a15-3109_4ex99d1.htm EX-99.1 10230
5 EX-99.2 a15-3109_4ex99d2.htm EX-99.2 10278
6 GRAPHIC g31094moi001.jpg GRAPHIC 3152
7 GRAPHIC g31094mmi001.jpg GRAPHIC 3417
8 GRAPHIC g31094kii001.jpg GRAPHIC 1980
  Complete submission text file 0001104659-15-005419.txt   413110
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 15559627
SIC: 2834 Pharmaceutical Preparations